{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:17:57Z","timestamp":1775978277890,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To identify lesion characteristics associated with restenosis after endovascular therapy (EVT) for common femoral artery (CFA) lesions in patients with peripheral artery disease (PAD) in real-world practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and Methods<\/jats:title>\n                <jats:p>We included 751 Japanese patients with PAD who underwent CFA EVT. Data were from a large-scale retrospective multicenter registry study. The association of lesion characteristics with the risk of restenosis was investigated with the Cox proportional hazards regression model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Lesions extended to the external iliac artery in 10.0% of patients, were isolated in the CFA in 59.9%, and involved the bifurcation in 30.1%. Chronic total occlusion was noted in 21.1%, and 99% stenosis, in 19.9%. Among the limbs with CFA lesions, 16.4% had a history of CFA EVT. Mean total lesion length was 32\u2009\u00b1\u200915\u00a0mm, and reference vessel diameter, 7.3\u2009\u00b1\u20091.4\u00a0mm. Plain old balloon angioplasty, drug-coated balloon angioplasty, and stent implantation were performed in 56.3, 23.2, and 20.5% of patients, respectively. The mean follow-up period was 10.4\u2009\u00b1\u20099.5\u00a0months. Rates of freedom from restenosis and reintervention at 1\u00a0year were 78.2 and 86.6%, respectively. Lesion characteristics independently associated with restenosis were history of CFA EVT, reference vessel diameter less than 6\u00a0mm, and lesion length greater than or equal to 50\u00a0mm; adjusted hazard ratios were 1.63 (<jats:italic>P<\/jats:italic>\u2009=\u20090.007), 1.93 (<jats:italic>P<\/jats:italic>\u2009=\u20090.006), and 1.71 (<jats:italic>P<\/jats:italic>\u2009=\u20090.018), respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>History of CFA EVT, smaller reference vessel diameter, and longer lesion length are independent risk factors for restenosis after CFA EVT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Level of Evidence<\/jats:title>\n                <jats:p>Level 3.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00270-022-03343-4","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T21:03:08Z","timestamp":1673384588000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lesion Characteristics Associated with Loss of Primary Patency After Endovascular Therapy for Common Femoral Artery Lesions"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1440-6349","authenticated-orcid":false,"given":"Yasutaka","family":"Yamauchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terutoshi","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On Behalf of the CAULIFLOWER Study Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"issue":"9","key":"3343_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MEL, Bj\u00f6rck M, Brodmann M, Cohnert T, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by\u2013\u2013the European stroke organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European society of cardiology (ESC) and of the European society for vascular surgery (ESVS). Eur Heart J. 2018;39(9):763\u2013816.","journal-title":"Eur Heart J"},{"issue":"11","key":"3343_CR2","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","volume":"69","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines. JACC. 2017;69(11):e71\u2013126.","journal-title":"JACC"},{"key":"3343_CR3","doi-asserted-by":"publisher","first-page":"1593401","DOI":"10.1155\/2019\/1593401","volume":"2019","author":"KH Changal","year":"2019","unstructured":"Changal KH, Syed MA, Dar T, Mangi MA, Sheikh MD. Systematic review and proportional meta-analysis of endarterectomy and endovascular therapy with routine or selective stenting for common femoral artery atherosclerotic disease. J Interv Cardiol. 2019;2019:1593401.","journal-title":"J Interv Cardiol"},{"issue":"6","key":"3343_CR4","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","volume":"69","author":"MS Conte","year":"2019","unstructured":"Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6):3S-125S.","journal-title":"J Vasc Surg"},{"issue":"4","key":"3343_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3400\/avd.cr.17-00041","volume":"10","author":"T Maruyama","year":"2017","unstructured":"Maruyama T, Miyamoto A. An endovascular strategy for occlusion or stenosis with severe calcification in the non-stenting zone, creatinG lumens and SlitS with crosser in unique technique (GLASS CUT): a case report. Ann Vasc Dis. 2017;10(4):426\u20139.","journal-title":"Ann Vasc Dis"},{"issue":"3","key":"3343_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s12928-013-0164-1","volume":"28","author":"Y Soga","year":"2013","unstructured":"Soga Y, Tomoi Y, Sato K, Iida O, Yokoi H. Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease. Cardiovasc Interv Ther. 2013;28(3):250\u20137.","journal-title":"Cardiovasc Interv Ther"},{"issue":"13","key":"3343_CR7","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jcin.2017.03.046","volume":"10","author":"Y Gou\u00ebffic","year":"2017","unstructured":"Gou\u00ebffic Y, Schiava ND, Thaveau F, Rosset E, Favre JP, du Mont LS, et al. Stenting or surgery for de novo common femoral artery stenosis. JACC Cardiovasc Interv. 2017;10(13):1344\u201354.","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"3343_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.jcin.2022.03.010","volume":"15","author":"T Nakama","year":"2022","unstructured":"Nakama T, Takahara M, Iwata Y, Fujimura N, Yamaoka T, Suzuki K, et al. 1-Year outcomes of thromboendarterectomy verus endovascular therapy for common femoral artery lesions. JACC Cardiovasc Interv. 2022;15(14):1453\u201363.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"3343_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ejvs.2011.02.025","volume":"41","author":"L Azema","year":"2011","unstructured":"Azema L, Davaine JM, Guyomarch B, Chaillou P, Costargent A, Patra P, et al. Endovascular repair of common femoral artery and concomitant arterial lesions. Eur J Vasc Endovasc Surg. 2011;41(6):787\u201393.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"3343_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","volume":"64","author":"MC Stoner","year":"2016","unstructured":"Stoner MC, Calligaro KD, Chaer RA, Dietzek AM, Farber A, Guzman RJ, et al. Reporting standards of the society for vascular surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg. 2016;64(1):e1\u201321.","journal-title":"J Vasc Surg"},{"issue":"4","key":"3343_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00270-021-03011-z","volume":"45","author":"M Rabellino","year":"2022","unstructured":"Rabellino M, Raleigh JV, Chiabrando JG, Caro VD, Chas J, Garagoli F, et al. Novel common femoral artery lesion classification in patients undergoing endovascular revascularization. Cardiovasc Intervent Radiol. 2022;45(4):438\u201347.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"3343_CR12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s00380-019-01524-9","volume":"35","author":"Y Yamauchi","year":"2020","unstructured":"Yamauchi Y, Takahara M, Iida O, Shintani Y, Sugano T, Yamamoto Y, et al. Independent predictors of loss of primary patency at 1 year after aortoiliac stent implantation. Heart Vessels. 2020;35(5):614\u20139.","journal-title":"Heart Vessels"},{"issue":"8","key":"3343_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jcin.2015.03.022","volume":"8","author":"O Iida","year":"2015","unstructured":"Iida O, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, et al. 1-year results of the ZEPHYR registry (zilver PTX for the femoral artery and proximal popliteal artery): predictors of restenosis. JACC Cardiovasc Interv. 2015;8(8):1105\u201312.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"3343_CR14","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jvs.2016.12.128","volume":"65","author":"S Hiramori","year":"2017","unstructured":"Hiramori S, Soga Y, Iida O, Suzuki K, Hirano K, Kawasaki D, et al. Relationship between clinical outcomes and vessel size in endovascular therapy for femoropopliteal lesions. J Vasc Surg. 2017;65(6):1690\u20137.","journal-title":"J Vasc Surg"},{"issue":"11","key":"3343_CR15","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1253\/circj.CJ-12-0492","volume":"76","author":"Y Soga","year":"2012","unstructured":"Soga Y, Iida O, Kawasaki D, Yamauchi Y, Suzuki K, Hirano K, et al. Contemporary outcomes after endovascular treatment for aorto-iliac artery disease. Circ J. 2012;76(11):2697\u2013704.","journal-title":"Circ J"},{"key":"3343_CR16","doi-asserted-by":"publisher","first-page":"103146","DOI":"10.1016\/j.amsu.2021.103146","volume":"72","author":"A Gheini","year":"2021","unstructured":"Gheini A, Shakarami A, Namdari P, Namdari M, Pooria A. Frequency of recurrence of peripheral artery disease among angioplasty and stenting patients. Ann Med Surg Lond. 2021;72:103146.","journal-title":"Ann Med Surg Lond"},{"issue":"8","key":"3343_CR17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jacc.2011.01.070","volume":"58","author":"RF Bonvini","year":"2011","unstructured":"Bonvini RF, Rastan A, Sixt S, Noory E, Schwarz T, Frank U, et al. Endovascular treatment of common femoral artery disease. JACC. 2011;58(8):792\u20138.","journal-title":"JACC"},{"issue":"4","key":"3343_CR18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jvs.2010.10.076","volume":"53","author":"F Baumann","year":"2011","unstructured":"Baumann F, Ruch M, Willenberg T, Dick F, Do D, Keo H, et al. Endovascular treatment of common femoral artery obstructions. J Vasc Surg. 2011;53(4):1000\u20136.","journal-title":"J Vasc Surg"},{"issue":"4","key":"3343_CR19","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jvs.2011.03.286","volume":"54","author":"Y Soga","year":"2011","unstructured":"Soga Y, Iida O, Hirano K, Suzuki K, Tosaka A, Yokoi H, et al. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. J Vasc Surg. 2011;54(4):1058\u201366.","journal-title":"J Vasc Surg"},{"issue":"3","key":"3343_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1067\/mva.2001.117148","volume":"34","author":"CH Timaran","year":"2001","unstructured":"Timaran CH, Stevens SL, Freeman MB, Goldman MH. External iliac and common iliac artery angioplasty and stenting in men and women. J Vasc Surg. 2001;34(3):440\u20136.","journal-title":"J Vasc Surg"},{"issue":"3","key":"3343_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","volume":"26","author":"RB Rutherford","year":"1997","unstructured":"Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517\u201338.","journal-title":"J Vasc Surg"},{"issue":"8","key":"3343_CR22","doi-asserted-by":"publisher","first-page":"e009168","DOI":"10.1161\/CIRCINTERVENTIONS.120.009168","volume":"13","author":"Y Yamauchi","year":"2020","unstructured":"Yamauchi Y, Takahara M, Shintani Y, Iida O, Sugano T, Yamamoto Y, et al. Three-year outcomes of endovascular therapy for aortoiliac lesions. Circ Cardiovasc Interv. 2020;13(8):e009168.","journal-title":"Circ Cardiovasc Interv"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03343-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T17:06:51Z","timestamp":1678813611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-022-03343-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3343"],"URL":"https:\/\/doi.org\/10.1007\/s00270-022-03343-4","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"15 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tatsuya Nakama is a consultant for BD, Boston Scientific, Century Medical, Cook Medical, Cordis Cardinal Health, Kaneka Medix, NIPRO, and OrbusNeich. Naoki Fujimura has received consulting fees from Cook Medical, Endologix, Medtronic, and W.L. Gore. Terutoshi Yamaoka has received consulting fees from Japan LIFELINE. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}